Try our Advanced Search for more refined results
Intellectual Property UK
-
April 02, 2025
Safestand Wins Appeal To Protect Scaffolding Design
An appellate judge on Wednesday reinstated a scaffolding manufacturer's three registered designs for builders' trestles, ruling that its many components all formed a single product rather than several alternative goods.
-
April 02, 2025
Microsoft Sued In Germany Over Video Coding Patents
Three licensors in Via LA's patent pool have sued Microsoft in Germany for allegedly infringing their essential video-coding patents through its sales of Windows and Xbox products, their lawyer said Wednesday.
-
April 02, 2025
Toy Seller Denies Copying Rival's 'Paw Bear' IP
A toy seller has fought back against claims that it copied a teddy bear design to steal customers, arguing that its rival was not the first company to give the stuffed animals a neck bow and rough patches.
-
April 02, 2025
Paddington Bear Owner Sues Souvenir Seller Over Copyright
The owner of Paddington Bear has hit a souvenir wholesaler with a copyright infringement claim in a London court, accusing it of using copies of the iconic bear on products without its permission.
-
April 01, 2025
AstraZeneca Keeps Generics Off Shelves Ahead Of Appeal
Counsel for AstraZeneca convinced the Court of Appeal on Monday to review a decision to let rival Glenmark release its generic version of a billion-dollar diabetes treatment under an agreement that the company can ship supplies of the drug already packed in trucks as long as it doesn't move ahead with retail sales in the meantime.
-
April 01, 2025
BAT Unit Can't Nix Philip Morris E-Cig Patent On Appeal
Philip Morris has retained its patent for a method of heating electronic cigarettes, with European officials tossing a challenge from a British American Tobacco unit after finding that Philip Morris' amended claims made the invention new.
-
April 01, 2025
Pfizer, Merck Lose Appeal To Patent Cancer Drug Dosage
European officials have rejected Pfizer and Merck's second bid to patent a specific cancer drug dosage, ruling that the pharmaceutical giants didn't provide any new justification to protect the treatment they developed together.
-
April 01, 2025
Nestlé's Smarties Brand Beats Low-Sugar 'Smart Sweets' TM
Nestlé has beaten a Canadian low-sugar candy maker's bid for a "Smart Sweets" trademark after European officials were persuaded that confectionery lovers were likely to confuse the brand with the multicolored chocolate Smarties.
-
April 01, 2025
Fire Alarm Patent Not New, Electrical Supplier Argues
An electrical equipment supplier has told a London court that a rival fire alarm manufacturer's patent for fire and carbon monoxide alarm systems is not viable because the supplier's competitor sold similar alarm systems before the patent was filed.
-
April 01, 2025
Hydrogen Tech Biz Must Hand IP To Inventor In Dutch Row
An inventor has persuaded a court in the Netherlands to order an energy company to hand over a group of applications for patents to extract hydrogen from water after concluding that he is the rightful owner.
-
April 01, 2025
Candey Denies Mishandling Client's Funds In Libel Dispute
Disputes firm Candey Ltd. has denied a claim by a former client that it mishandled her money following a settlement in a trademark dispute, while pressing home its allegation that her one-star Google review of its performance was defamatory.
-
March 31, 2025
Novartis, Genentech Lose Asthma Drug Patent In Netherlands
Celltrion Inc. has persuaded a Dutch court to revoke Novartis and Genentech's patent in the Netherlands for asthma drug omalizumab, straying from a London judge's recent decision to uphold the U.K. part of the patent.
-
March 31, 2025
Boult Wade Atty Named Chief Of IP Group's UK Arm
A European intellectual property union has named a Boult Wade Tennant LLP partner as the new president of its British group.
-
March 31, 2025
Adidas Refused Broader Protection For Sports Shoe Patent
European patent officials have rejected a bid by Adidas AG for a broader version of a patent for one of its sports shoe designs but disagreed with a Swiss competitor that the patent should be scrapped entirely.
-
March 31, 2025
Session Musicians Need Streaming Revenue Fix, Union Says
The Musicians' Union has pushed the government to give session musicians a share of streaming royalties, noting that a recent increase in upfront studio fees wasn't enough to balance the scales given the streaming industry's gains.
-
March 31, 2025
LVMH Units Win Glenmorangie, Belvedere Counterfeits Claim
Two LVMH-owned companies behind Scotch whisky brand Glenmorangie and Polish vodka Belvedere have convinced a court in the Netherlands that a Chinese company infringed their trademarks by importing and storing thousands of counterfeit bottles.
-
March 31, 2025
Nokia, Amazon End Long-Running Patent Feud With License
Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.
-
March 28, 2025
Patent Court Likely To Lure Patent Holders With UK IP In Play
The Unified Patent Court has now doubled down on its authority to hear claims involving U.K. patents, a move that is likely to make the court an even more desirable forum for global infringement actions.
-
March 28, 2025
VistaJet Escapes VC Fund's Claim Over Investment Deal
A private jet company owner escaped allegations from a Guernsey venture capital fund that he secretly set up companies to leverage the resources of a business it had invested in, when a London court ruled Friday that the claim came too late.
-
March 28, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.
-
March 28, 2025
CureVac RNA Vax Patent Survives BioNTech's EU Challenge
CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.
-
March 28, 2025
Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival
A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned.
-
March 28, 2025
MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban
A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.
-
March 28, 2025
AstraZeneca Can't Stop Generic Diabetes Drug Launch
AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.
-
March 27, 2025
AstraZeneca Fights Generic Diabetes Drug Launch
AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.
Expert Analysis
-
Germany's Google Controls Illustrate Global Antitrust Trend
Germany's recent move to rein in Google with extended restrictions on anti-competitive behavior provides an example of the new aggressive stance regulators around the world are adopting as tech giants grow their power in the digital economy, says Andrea Pomana at ADVANT Beiten.
-
Opinion
Solution To Patent Eligibility Quagmire Lies In Constitution
A lack of clarity on patent eligibility has undermined the credibility of the patent system, and a possible resolution is for courts or Congress to define judicial exceptions to patent-eligible subject matter in their most concise form — in line with constitutional guarantees, says Indi Rajasingham at the Mmillenniumm Group.
-
Examining EU's Drift Toward US-Style Employer Pact Scrutiny
As European Union competition authorities express enforcement interest in employment issues such as no-poach and wage-fixing agreements — which have been the subject of U.S. enforcement action for some time — companies may need to recalibrate their training and compliance programs accordingly, say attorneys at Crowell & Moring.
-
What SEP Holders Can Take Away From UK's Apple Ruling
A U.K. court's recent decision in the standard essential patent dispute between Apple and Optis Cellular Technology provides encouragement for SEP owners litigating their portfolios in the U.K. and reaffirms the country's place as a patentee-friendly jurisdiction, says Tess Waldron at Powell Gilbert.
-
AI Inventorship Decision Leaves Open Questions
A Virginia federal court's recent decision in Thaler v. Iancu, finding that artificial intelligence cannot be named as a patent inventor, highlights questions that will have to be answered as AI increasingly contributes to inventorship, especially in the pharmaceutical industry, say attorneys at DLA Piper.
-
What Patent Applications Signal About Green Energy Trends
Steadily increasing patent activity related to clean energy technologies suggests that the proportion of energy derived from green sources will also continue to grow — but smaller companies could be locked out of the patent race, even as sustainability becomes an inescapable business imperative, says Greg Sharp at Haseltine Lake.
-
Takeaways On Pre-Action Protocols From UK Patent Ruling
The U.K. High Court's recent patent ruling in Add2 Research v. dSpace instructs parties in proper pre-action discussions that avoid breaches of protocol, including how to provide materials in confidence, say Angela Jack and Emily Atherton at EIP.
-
6 Ways To Guide Applications Under New Patent Classification
Intellectual property practitioners can navigate the recently implemented Cooperative Patent Classification system to direct applications to specific prior art units within the U.S. Patent and Trademark Office, avoid especially difficult units, and improve clients' portfolios in newly emerging technologies, say Roberta Young and Brian Michaelis at Seyfarth.
-
Mitigating User Content Risk After EU Copyright Directive
As the deadline approaches for member states to implement the European Union’s new copyright directive, which will hold certain online content service providers liable for copyright infringement pertaining to user-uploaded content, companies should have risk-mitigation strategies in place, say attorneys at MoFo.
-
The Pandemic's Bright Spots For Lawyers Who Are Parents
The COVID-19 crisis has allowed lawyers to hone remote advocacy strategies and effectively represent clients with minimal travel — abilities that have benefited working parents and should be utilized long after the pandemic is over, says Chelsea Loughran at Wolf Greenfield.
-
ITC Seems Unlikely To Stay Investigations For Parallel IPRs
The U.S. International Trade Commission's recent order denying Ocado's attempt to stay a dispute with AutoStore pending resolution of its inter partes review petitions signals that an ITC complainant's patents are effectively shielded from IPR challenges, at least under current Patent Trial and Appeal Board practice, say attorneys at Reichman Jorgensen.
-
A Framework For Evaluating Willingness Of FRAND Licensees
As an increasing number of standard-essential patent cases turn on whether a manufacturer is willing to pay a fair, reasonable and nondiscriminatory royalty for SEPs, Jorge Contreras at the University of Utah identifies conduct that typically indicates willingness or unwillingness, as well as conduct that should be viewed as indeterminate.
-
Opinion
US Should Learn From German Courts Balancing SEP Rights
The German high court's recent decision in Sisvel v. Haier set a productive tone in balancing the rights of patentees and implementers in standard-essential patent disputes, and its understanding of negotiation realities should be followed by the U.S., say Cravath's David Kappos, former U.S. Patent and Trademark Office director, and Daniel Etcovitch.
-
Examining EPO's Strict Approach To AI Patent Disclosure
Because a recent decision by the European Patent Office Boards of Appeal takes a potentially problematic strict approach to disclosure requirements for machine learning-related patent applications, U.S. applicants filing in the EU should disclose several specific data training sets, says Ronny Amirsehhi at Clifford Chance.
-
ITC Dispute May Lead To PTAB Litigation Strategy Shifts
A pending motion to stay the dispute between AutoStore and Ocado at the U.S. International Trade Commission highlights competing timelines of the ITC and Patent Trial and Appeal Board, and has the potential to reshape the typical forum selection strategies for patentees and defense tactics for challengers, say attorneys at Reichman Jorgensen.